Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb14
|
ENSMUSG00000049672.8 | zinc finger and BTB domain containing 14 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_69382413_69382607 | Zbtb14 | 540 | 0.676901 | -0.27 | 3.9e-02 | Click! |
chr17_69381833_69381984 | Zbtb14 | 1142 | 0.399734 | -0.12 | 3.6e-01 | Click! |
chr17_69383150_69383834 | Zbtb14 | 173 | 0.859440 | 0.02 | 8.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_132740444_132742155 | 16.73 |
Nfasc |
neurofascin |
458 |
0.83 |
chr1_109982396_109983459 | 10.16 |
Cdh7 |
cadherin 7, type 2 |
54 |
0.99 |
chr11_82434143_82435365 | 9.97 |
Tmem132e |
transmembrane protein 132E |
3503 |
0.29 |
chr7_46179165_46180456 | 9.47 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
176 |
0.92 |
chr15_78718540_78719194 | 9.42 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
96 |
0.96 |
chr9_58197310_58202560 | 8.48 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr7_44335441_44336039 | 8.21 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
276 |
0.76 |
chr9_22050521_22051976 | 8.07 |
Elavl3 |
ELAV like RNA binding protein 3 |
762 |
0.41 |
chr3_88214322_88216234 | 8.01 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr11_61022134_61023265 | 8.01 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
135 |
0.96 |
chr6_127768524_127769705 | 7.68 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr1_42697532_42698715 | 7.64 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr5_125532320_125533519 | 7.31 |
Tmem132b |
transmembrane protein 132B |
532 |
0.76 |
chr1_136259745_136260967 | 7.30 |
Gpr25 |
G protein-coupled receptor 25 |
517 |
0.54 |
chr7_44336079_44337576 | 7.29 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr19_47014128_47015152 | 7.26 |
Ina |
internexin neuronal intermediate filament protein, alpha |
58 |
0.88 |
chr9_45430098_45431532 | 7.23 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
417 |
0.52 |
chr12_61523440_61524787 | 7.20 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
165 |
0.95 |
chr1_119420327_119420935 | 7.17 |
Inhbb |
inhibin beta-B |
1617 |
0.38 |
chr8_99415302_99416849 | 7.04 |
Cdh8 |
cadherin 8 |
244 |
0.77 |
chrX_64275723_64277215 | 7.03 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
510 |
0.87 |
chr3_17790150_17790808 | 6.92 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
522 |
0.77 |
chr8_12915306_12916734 | 6.82 |
Mcf2l |
mcf.2 transforming sequence-like |
45 |
0.76 |
chr5_130448513_130449808 | 6.80 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr7_121391567_121393161 | 6.73 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr15_89840994_89842160 | 6.68 |
Syt10 |
synaptotagmin X |
283 |
0.93 |
chr11_97573801_97574201 | 6.56 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
46 |
0.96 |
chr7_109010827_109011701 | 6.48 |
Tub |
tubby bipartite transcription factor |
439 |
0.81 |
chr7_131966504_131967699 | 6.39 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr8_65617917_65619195 | 6.38 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
31 |
0.99 |
chr11_74589375_74590721 | 6.31 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
76 |
0.97 |
chr19_6497246_6498663 | 6.29 |
Nrxn2 |
neurexin II |
119 |
0.94 |
chr15_101438228_101439215 | 6.25 |
Krt87 |
keratin 87 |
83 |
0.92 |
chr8_4216103_4217573 | 6.21 |
Prr36 |
proline rich 36 |
74 |
0.93 |
chr9_4795419_4796481 | 6.10 |
Gria4 |
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
192 |
0.97 |
chr13_110279614_110280243 | 5.98 |
Rab3c |
RAB3C, member RAS oncogene family |
222 |
0.95 |
chr2_19909579_19910504 | 5.87 |
Etl4 |
enhancer trap locus 4 |
261 |
0.91 |
chr2_152081612_152083149 | 5.86 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr10_29143400_29144848 | 5.86 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr6_103510606_103512502 | 5.83 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
chr7_129256430_129257706 | 5.81 |
Plpp4 |
phospholipid phosphatase 4 |
13 |
0.99 |
chr12_29536127_29536438 | 5.73 |
Myt1l |
myelin transcription factor 1-like |
1060 |
0.47 |
chr19_47016270_47016724 | 5.72 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1344 |
0.28 |
chr8_121729721_121730922 | 5.65 |
Jph3 |
junctophilin 3 |
242 |
0.9 |
chr1_89968038_89969020 | 5.64 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
27923 |
0.16 |
chr5_117241784_117242411 | 5.63 |
Taok3 |
TAO kinase 3 |
1637 |
0.3 |
chr10_109008310_109009456 | 5.63 |
Syt1 |
synaptotagmin I |
217 |
0.96 |
chr18_23309850_23311104 | 5.60 |
Gm7788 |
predicted gene 7788 |
93808 |
0.08 |
chr9_56795792_56797095 | 5.52 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
25 |
0.97 |
chr19_47015226_47015567 | 5.45 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
243 |
0.78 |
chr4_22491084_22492166 | 5.39 |
Gm30731 |
predicted gene, 30731 |
1077 |
0.46 |
chr1_9298603_9300104 | 5.33 |
Sntg1 |
syntrophin, gamma 1 |
71 |
0.97 |
chr7_119184137_119185474 | 5.28 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chr12_5374545_5374864 | 5.25 |
Klhl29 |
kelch-like 29 |
978 |
0.45 |
chr17_24689022_24690262 | 5.24 |
Syngr3 |
synaptogyrin 3 |
313 |
0.69 |
chr14_68123421_68125146 | 5.23 |
Nefm |
neurofilament, medium polypeptide |
563 |
0.74 |
chr8_93812106_93812875 | 5.20 |
Gnao1 |
guanine nucleotide binding protein, alpha O |
1177 |
0.35 |
chr8_12396308_12397229 | 5.18 |
Gm25239 |
predicted gene, 25239 |
365 |
0.77 |
chr2_21367263_21369086 | 5.17 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr11_118568846_118570341 | 5.15 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
317 |
0.91 |
chr16_5884597_5886147 | 5.13 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr4_124893834_124895373 | 5.12 |
1700125G02Rik |
RIKEN cDNA 1700125G02 gene |
179 |
0.9 |
chr3_31309226_31310664 | 5.12 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr15_89453545_89454765 | 5.11 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
242 |
0.82 |
chr8_17532221_17533470 | 5.09 |
Csmd1 |
CUB and Sushi multiple domains 1 |
2436 |
0.46 |
chr5_49524106_49524873 | 5.02 |
Kcnip4 |
Kv channel interacting protein 4 |
275 |
0.91 |
chr9_111311563_111312866 | 5.02 |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
118 |
0.97 |
chr10_73099097_73100287 | 5.01 |
Pcdh15 |
protocadherin 15 |
239 |
0.94 |
chr11_35797548_35798866 | 5.00 |
Fbll1 |
fibrillarin-like 1 |
677 |
0.62 |
chr2_25318080_25319601 | 4.98 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr16_9994378_9995594 | 4.97 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr6_120492177_120492905 | 4.96 |
Tmem121b |
transmembrane protein 121B |
1266 |
0.34 |
chr5_35280361_35280996 | 4.90 |
Adra2c |
adrenergic receptor, alpha 2c |
2359 |
0.33 |
chr7_141949754_141950818 | 4.87 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr6_136172206_136173574 | 4.87 |
Gm26653 |
predicted gene, 26653 |
171 |
0.59 |
chr7_79709789_79711095 | 4.84 |
9330171B17Rik |
RIKEN cDNA 9330171B17 gene |
71 |
0.94 |
chr9_91363965_91365514 | 4.80 |
Zic1 |
zinc finger protein of the cerebellum 1 |
1029 |
0.35 |
chr4_124861345_124862773 | 4.79 |
Maneal |
mannosidase, endo-alpha-like |
112 |
0.93 |
chr7_92234907_92236280 | 4.77 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr6_90781027_90782541 | 4.67 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr6_91843070_91844089 | 4.65 |
Grip2 |
glutamate receptor interacting protein 2 |
16329 |
0.15 |
chr13_105444000_105445296 | 4.64 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr15_100615290_100615480 | 4.61 |
Dazap2 |
DAZ associated protein 2 |
36 |
0.76 |
chr8_36457557_36458639 | 4.61 |
Trmt9b |
tRNA methyltransferase 9B |
84 |
0.97 |
chr13_78194785_78195954 | 4.60 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1004 |
0.42 |
chr12_16653378_16654213 | 4.60 |
Ntsr2 |
neurotensin receptor 2 |
37 |
0.97 |
chr16_6348470_6349707 | 4.59 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
50 |
0.99 |
chrX_57503221_57504242 | 4.58 |
Gpr101 |
G protein-coupled receptor 101 |
26 |
0.98 |
chr11_71750709_71751963 | 4.58 |
Wscd1 |
WSC domain containing 1 |
40 |
0.97 |
chr6_119328752_119331284 | 4.55 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr15_87544354_87545329 | 4.53 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr6_119107253_119107430 | 4.52 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
634 |
0.81 |
chr1_42686011_42687379 | 4.51 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr8_87472820_87473580 | 4.50 |
Gm2694 |
predicted gene 2694 |
43 |
0.9 |
chr10_41072016_41072570 | 4.46 |
Gpr6 |
G protein-coupled receptor 6 |
8 |
0.97 |
chr15_34837199_34838365 | 4.45 |
Kcns2 |
K+ voltage-gated channel, subfamily S, 2 |
267 |
0.93 |
chr19_46326421_46327493 | 4.44 |
Psd |
pleckstrin and Sec7 domain containing |
164 |
0.86 |
chr4_125490136_125491914 | 4.42 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr16_67617739_67618070 | 4.41 |
Cadm2 |
cell adhesion molecule 2 |
2589 |
0.35 |
chr15_74516560_74519631 | 4.41 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
1264 |
0.47 |
chr15_75565940_75567228 | 4.38 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
48 |
0.96 |
chr19_22447648_22448999 | 4.35 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr6_91409540_91411888 | 4.35 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
649 |
0.42 |
chr18_75820188_75820888 | 4.34 |
Zbtb7c |
zinc finger and BTB domain containing 7C |
323 |
0.91 |
chr15_83780142_83780827 | 4.30 |
Mpped1 |
metallophosphoesterase domain containing 1 |
461 |
0.86 |
chr11_82388570_82389922 | 4.29 |
Tmem132e |
transmembrane protein 132E |
123 |
0.96 |
chr9_122571762_122573193 | 4.27 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
22 |
0.97 |
chr13_57907102_57908323 | 4.27 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
125 |
0.98 |
chr17_15374606_15376160 | 4.27 |
Dll1 |
delta like canonical Notch ligand 1 |
283 |
0.89 |
chr1_84934038_84935232 | 4.25 |
Slc16a14 |
solute carrier family 16 (monocarboxylic acid transporters), member 14 |
222 |
0.91 |
chr7_82335360_82336568 | 4.25 |
Adamtsl3 |
ADAMTS-like 3 |
232 |
0.93 |
chr6_22875139_22876535 | 4.25 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
60 |
0.98 |
chr9_31913042_31914060 | 4.25 |
Barx2 |
BarH-like homeobox 2 |
89 |
0.96 |
chr5_117414146_117414959 | 4.24 |
Ksr2 |
kinase suppressor of ras 2 |
552 |
0.7 |
chr9_26733362_26733763 | 4.23 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
166 |
0.94 |
chr1_34750294_34751404 | 4.22 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
268 |
0.85 |
chr2_104409773_104410863 | 4.21 |
D430041D05Rik |
RIKEN cDNA D430041D05 gene |
16 |
0.97 |
chr4_149675232_149676050 | 4.21 |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
16 |
0.97 |
chr19_41742559_41744061 | 4.20 |
Slit1 |
slit guidance ligand 1 |
176 |
0.96 |
chr1_192190419_192191087 | 4.20 |
Kcnh1 |
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
21 |
0.98 |
chr7_51621596_51622924 | 4.15 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr12_73997294_73998377 | 4.14 |
Syt16 |
synaptotagmin XVI |
36 |
0.97 |
chr11_11115362_11116603 | 4.14 |
Vwc2 |
von Willebrand factor C domain containing 2 |
131 |
0.97 |
chr15_74563319_74564610 | 4.12 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr5_110386046_110387130 | 4.11 |
Fbrsl1 |
fibrosin-like 1 |
374 |
0.79 |
chr5_128432188_128433399 | 4.10 |
Tmem132d |
transmembrane protein 132D |
284 |
0.89 |
chr8_113847926_113849082 | 4.09 |
Adamts18 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
111 |
0.98 |
chrX_71962278_71963567 | 4.07 |
Prrg3 |
proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) |
60 |
0.97 |
chr4_149586203_149587699 | 4.05 |
Clstn1 |
calsyntenin 1 |
297 |
0.85 |
chr19_48205036_48205839 | 4.05 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
588 |
0.8 |
chr1_23761798_23762867 | 4.03 |
B3gat2 |
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
321 |
0.93 |
chr4_119138078_119138899 | 4.02 |
Gm12868 |
predicted gene 12868 |
313 |
0.79 |
chr5_120710211_120711265 | 4.01 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chr13_104914221_104914837 | 3.99 |
Gm4938 |
predicted pseudogene 4938 |
4251 |
0.27 |
chr4_127987663_127988221 | 3.98 |
Csmd2 |
CUB and Sushi multiple domains 2 |
85 |
0.98 |
chr1_87153907_87155134 | 3.98 |
Ecel1 |
endothelin converting enzyme-like 1 |
507 |
0.63 |
chr9_40344899_40346384 | 3.94 |
Gramd1b |
GRAM domain containing 1B |
649 |
0.55 |
chr12_75176309_75177605 | 3.93 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr15_79803804_79804650 | 3.92 |
Nptxr |
neuronal pentraxin receptor |
482 |
0.67 |
chr6_38662686_38663789 | 3.90 |
Clec2l |
C-type lectin domain family 2, member L |
170 |
0.95 |
chr17_6489757_6490685 | 3.90 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
23199 |
0.14 |
chr12_5373829_5374490 | 3.89 |
Klhl29 |
kelch-like 29 |
1523 |
0.37 |
chr15_85670346_85670889 | 3.88 |
Lncppara |
long noncoding RNA near Ppara |
17001 |
0.13 |
chr10_33623738_33624906 | 3.87 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr1_152955506_152956322 | 3.86 |
Nmnat2 |
nicotinamide nucleotide adenylyltransferase 2 |
640 |
0.67 |
chrX_64277266_64277417 | 3.86 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
345 |
0.93 |
chr5_26817077_26818245 | 3.83 |
Dpp6 |
dipeptidylpeptidase 6 |
227 |
0.94 |
chr10_84756349_84757352 | 3.81 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
788 |
0.69 |
chr9_65519803_65520935 | 3.81 |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
176 |
0.92 |
chr17_6320795_6321910 | 3.81 |
AC183097.1 |
transmembrane protein 181 (TMEM181) pseudogene |
384 |
0.76 |
chr12_80518501_80519034 | 3.80 |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
35 |
0.64 |
chr9_36832384_36834135 | 3.80 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
376 |
0.83 |
chr14_79768163_79769199 | 3.77 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr11_104132745_104133730 | 3.76 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
382 |
0.88 |
chr9_122568771_122569959 | 3.76 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
3134 |
0.2 |
chr13_12105751_12107037 | 3.75 |
Ryr2 |
ryanodine receptor 2, cardiac |
65 |
0.97 |
chr7_126823319_126824529 | 3.75 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr15_54571022_54571454 | 3.75 |
Mal2 |
mal, T cell differentiation protein 2 |
46 |
0.98 |
chr18_23040818_23041662 | 3.74 |
Nol4 |
nucleolar protein 4 |
413 |
0.91 |
chr19_4711641_4712943 | 3.70 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
92 |
0.94 |
chr5_35278810_35279135 | 3.67 |
Adra2c |
adrenergic receptor, alpha 2c |
653 |
0.75 |
chr4_140245362_140247262 | 3.64 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr7_37768924_37769455 | 3.63 |
Zfp536 |
zinc finger protein 536 |
435 |
0.87 |
chr17_6256598_6257723 | 3.62 |
Tmem181a |
transmembrane protein 181A |
210 |
0.91 |
chr7_4843778_4845015 | 3.62 |
Shisa7 |
shisa family member 7 |
300 |
0.77 |
chr13_13393555_13394196 | 3.61 |
Gpr137b |
G protein-coupled receptor 137B |
139 |
0.93 |
chr13_78202666_78203848 | 3.61 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
470 |
0.74 |
chr1_38897270_38898379 | 3.60 |
Chst10 |
carbohydrate sulfotransferase 10 |
162 |
0.94 |
chr1_170907327_170908654 | 3.60 |
Fcrlb |
Fc receptor-like B |
4951 |
0.1 |
chr15_84853334_84853909 | 3.59 |
Phf21b |
PHD finger protein 21B |
1489 |
0.34 |
chr4_153482229_153483249 | 3.58 |
Ajap1 |
adherens junction associated protein 1 |
72 |
0.99 |
chr5_131306365_131308106 | 3.58 |
Galnt17 |
polypeptide N-acetylgalactosaminyltransferase 17 |
320 |
0.93 |
chr7_123982468_123983092 | 3.57 |
Hs3st4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
89 |
0.91 |
chr4_49844475_49845850 | 3.57 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
387 |
0.91 |
chr4_148286849_148288201 | 3.56 |
Disp3 |
dispatched RND transporter family member 3 |
440 |
0.81 |
chrX_5467696_5468887 | 3.56 |
Mycs |
myc-like oncogene, s-myc protein |
974 |
0.62 |
chr2_42652202_42653456 | 3.56 |
Lrp1b |
low density lipoprotein-related protein 1B |
97 |
0.98 |
chr3_86919646_86920874 | 3.55 |
Dclk2 |
doublecortin-like kinase 2 |
72 |
0.96 |
chr12_117150370_117151613 | 3.54 |
Gm10421 |
predicted gene 10421 |
224 |
0.96 |
chr1_42684511_42685482 | 3.54 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8097 |
0.14 |
chr15_83779433_83779836 | 3.54 |
Mpped1 |
metallophosphoesterase domain containing 1 |
167 |
0.96 |
chr9_26733853_26734637 | 3.53 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
394 |
0.83 |
chr4_124658606_124659175 | 3.53 |
Gm2164 |
predicted gene 2164 |
1721 |
0.21 |
chr15_99670221_99671432 | 3.52 |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
458 |
0.66 |
chr7_122670691_122671255 | 3.52 |
Cacng3 |
calcium channel, voltage-dependent, gamma subunit 3 |
418 |
0.85 |
chr9_121777534_121778713 | 3.51 |
Gm47108 |
predicted gene, 47108 |
23 |
0.86 |
chrX_104201289_104201643 | 3.51 |
Nexmif |
neurite extension and migration factor |
281 |
0.93 |
chr13_83739310_83740387 | 3.50 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr3_55242295_55243824 | 3.49 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr5_66745428_66746731 | 3.47 |
Limch1 |
LIM and calponin homology domains 1 |
190 |
0.94 |
chr11_112784278_112785462 | 3.46 |
Sox9 |
SRY (sex determining region Y)-box 9 |
2646 |
0.24 |
chr7_19282758_19283683 | 3.46 |
Rtn2 |
reticulon 2 (Z-band associated protein) |
585 |
0.49 |
chr1_25829353_25830710 | 3.45 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
324 |
0.65 |
chr2_152950712_152951086 | 3.42 |
Dusp15 |
dual specificity phosphatase-like 15 |
557 |
0.65 |
chr7_84528418_84529713 | 3.41 |
Gm2115 |
predicted gene 2115 |
73 |
0.97 |
chr1_93100315_93101980 | 3.40 |
Kif1a |
kinesin family member 1A |
675 |
0.62 |
chr9_24695659_24696739 | 3.40 |
Dpy19l2 |
dpy-19-like 2 (C. elegans) |
94 |
0.98 |
chr1_132880197_132881455 | 3.40 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
471 |
0.81 |
chr7_105425216_105426515 | 3.38 |
Cckbr |
cholecystokinin B receptor |
48 |
0.95 |
chr8_71685721_71686960 | 3.38 |
Insl3 |
insulin-like 3 |
2874 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 16.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.9 | 17.3 | GO:0046958 | nonassociative learning(GO:0046958) |
2.6 | 2.6 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.6 | 7.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.2 | 6.5 | GO:0021586 | pons maturation(GO:0021586) |
2.1 | 6.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.1 | 8.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.7 | 1.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.7 | 5.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.7 | 8.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.6 | 6.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.6 | 4.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.5 | 4.5 | GO:0021564 | vagus nerve development(GO:0021564) |
1.5 | 14.9 | GO:0071625 | vocalization behavior(GO:0071625) |
1.4 | 7.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.4 | 4.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.4 | 4.1 | GO:0001757 | somite specification(GO:0001757) |
1.4 | 5.4 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.4 | 9.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.3 | 5.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.3 | 28.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.3 | 3.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.3 | 2.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.3 | 5.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.3 | 8.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.2 | 3.7 | GO:0015888 | thiamine transport(GO:0015888) |
1.2 | 3.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 3.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.2 | 2.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.2 | 3.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.2 | 8.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 7.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.2 | 1.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.1 | 4.6 | GO:1902837 | amino acid import into cell(GO:1902837) |
1.1 | 3.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 3.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.1 | 2.1 | GO:0009629 | response to gravity(GO:0009629) |
1.1 | 2.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.1 | 4.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.0 | 2.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.0 | 12.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.0 | 22.9 | GO:0035640 | exploration behavior(GO:0035640) |
1.0 | 4.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.0 | 3.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 3.0 | GO:1903416 | response to glycoside(GO:1903416) |
1.0 | 4.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.0 | 3.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.0 | 2.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 1.0 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.0 | 2.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.0 | 7.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.9 | 3.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.9 | 10.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 2.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 2.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 0.9 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.9 | 4.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.9 | 7.0 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.9 | 1.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 7.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.9 | 7.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 0.9 | GO:0060594 | mammary gland specification(GO:0060594) |
0.9 | 3.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.9 | 1.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 1.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 3.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.8 | 0.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.8 | 2.5 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.8 | 9.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.8 | 1.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.8 | 2.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 4.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.8 | 6.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 4.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.8 | 4.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.8 | 1.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 2.3 | GO:0097503 | sialylation(GO:0097503) |
0.8 | 2.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.8 | 3.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 3.0 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 2.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 1.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 2.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.7 | 2.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 3.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.7 | 2.2 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.7 | 2.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 1.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.7 | 2.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.7 | 13.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 0.7 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.7 | 2.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.7 | 1.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.7 | 2.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.7 | 4.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 1.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 2.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 3.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 9.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 4.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.7 | 1.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.7 | 2.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.7 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 5.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.6 | 1.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.9 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.6 | 2.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 32.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 1.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 1.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.6 | 5.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.6 | 7.6 | GO:0001964 | startle response(GO:0001964) |
0.6 | 51.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 7.5 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.6 | 1.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.6 | 2.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.6 | 10.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.6 | 1.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 3.7 | GO:0042637 | catagen(GO:0042637) |
0.6 | 1.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.6 | 4.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.6 | 6.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.6 | 1.8 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.6 | 2.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 1.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 1.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 2.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 1.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.6 | 4.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 4.8 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.6 | 1.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.6 | 1.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 3.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 0.6 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.6 | 1.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.6 | 0.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 1.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 3.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.5 | 2.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 16.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.5 | 3.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.5 | 2.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 3.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.5 | 1.6 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 1.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.5 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 8.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 1.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 1.5 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.5 | 2.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.5 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.5 | 1.0 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.5 | 4.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.5 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 2.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 1.0 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 5.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 0.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 0.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 3.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 1.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.5 | 0.5 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.5 | 0.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 2.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 4.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.4 | 2.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 8.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 2.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 2.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 1.7 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.4 | 1.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 1.7 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.4 | 5.1 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.4 | 1.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.4 | 1.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 2.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.4 | 4.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.4 | 2.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 3.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.4 | 1.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 1.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 0.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 1.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.4 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 1.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 0.8 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.4 | 0.8 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 1.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 0.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.4 | 0.8 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.4 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.4 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.4 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 1.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 1.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 11.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.4 | 0.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 6.1 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.4 | 1.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 1.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 2.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.4 | 2.1 | GO:0021794 | thalamus development(GO:0021794) |
0.4 | 4.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 1.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 3.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 1.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 2.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 1.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 1.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 3.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.3 | 1.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 2.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 3.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 1.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 0.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.7 | GO:0010958 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.3 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 9.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 1.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 0.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 1.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 0.3 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.3 | 1.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.9 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.3 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 2.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 1.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 0.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 2.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 1.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 2.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 19.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 13.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 0.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 | 1.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 2.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 3.9 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.3 | 0.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 1.1 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 0.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 4.2 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 2.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 0.3 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.3 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 1.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 2.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 6.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 1.0 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.5 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 2.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 21.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 4.1 | GO:0071475 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 1.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 10.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 1.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.5 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 1.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 3.8 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.9 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.5 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 1.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.2 | 0.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 3.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 1.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 2.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 4.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 2.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.2 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 3.7 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.2 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 2.0 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 1.4 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.2 | 0.4 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.8 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 2.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 1.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 3.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 1.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 3.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.5 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 6.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.5 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 1.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.2 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 1.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 1.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.8 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 3.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 1.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.4 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 1.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 3.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 1.7 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 2.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.2 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.2 | GO:0021544 | subpallium development(GO:0021544) |
0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 1.3 | GO:0030817 | regulation of cAMP biosynthetic process(GO:0030817) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 4.1 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 5.2 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.1 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.1 | 0.3 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 1.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.2 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 1.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 1.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.5 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.3 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 1.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.7 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) regulation of eosinophil activation(GO:1902566) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.7 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.1 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.1 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.7 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.3 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.1 | 1.0 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 2.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 4.3 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.9 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.9 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.7 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.2 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.0 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 2.4 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.0 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.0 | 0.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 2.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.6 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.3 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.0 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 2.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0009261 | ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
2.0 | 10.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.9 | 23.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.7 | 15.0 | GO:0005883 | neurofilament(GO:0005883) |
1.6 | 4.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.5 | 4.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.3 | 7.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.2 | 7.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.2 | 3.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.1 | 3.3 | GO:0032280 | symmetric synapse(GO:0032280) |
1.0 | 13.6 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.0 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.0 | 8.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 4.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.0 | 6.0 | GO:0033268 | node of Ranvier(GO:0033268) |
1.0 | 10.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.9 | 14.1 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 26.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.9 | 2.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 2.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 1.6 | GO:0044393 | microspike(GO:0044393) |
0.7 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.7 | 2.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 47.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 5.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 3.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 9.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 3.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 22.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 10.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 4.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 13.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 2.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 65.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 2.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 1.9 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 12.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 1.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 5.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 0.8 | GO:0034705 | potassium channel complex(GO:0034705) |
0.4 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 2.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 6.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 9.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 0.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 3.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 26.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 11.0 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 8.7 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 2.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 33.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.7 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 3.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 4.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 13.5 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 1.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 3.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 1.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 9.7 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.1 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 1.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 6.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 3.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 2.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 3.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 5.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 5.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 33.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 3.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 6.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.8 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 22.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 8.9 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.2 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 6.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.5 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 3.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 3.6 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 49.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 199.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 2.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 5.4 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 4.3 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.6 | GO:0001725 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.6 | 14.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.1 | 9.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.1 | 15.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.9 | 14.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.2 | 8.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.8 | 5.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.7 | 5.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.7 | 1.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.7 | 8.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.6 | 4.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.5 | 12.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.5 | 2.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.5 | 5.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 5.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.3 | 4.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.3 | 5.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 3.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.1 | 8.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.1 | 3.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.1 | 6.4 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 4.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.0 | 3.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.0 | 2.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.9 | 4.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 2.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 1.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.8 | 6.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 2.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.8 | 4.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 3.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 4.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 2.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 5.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.7 | 9.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 21.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 3.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 7.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 0.7 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 2.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 2.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 3.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 33.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.6 | 11.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 1.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 1.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 3.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 4.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 8.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 2.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 7.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 10.1 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 11.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 3.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 2.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 3.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 2.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 2.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 5.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 3.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.5 | 2.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 2.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 2.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 2.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 3.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 13.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 18.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 6.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 1.4 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 17.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.4 | 5.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 7.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 12.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.4 | 1.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 3.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 5.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 5.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 1.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 1.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 3.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 0.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 1.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 4.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 2.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 0.4 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.4 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 2.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 3.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 7.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 3.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 9.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 1.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 1.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 6.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 4.1 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 3.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 2.8 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 11.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 2.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 12.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 5.7 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.3 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 2.3 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.3 | 6.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.3 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 3.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 6.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 4.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 2.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 6.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 6.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 4.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 2.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 1.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 4.7 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 4.6 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.2 | 4.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 5.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.9 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.2 | 2.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 21.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 2.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 5.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.6 | GO:0018555 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 0.6 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 3.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 2.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 0.2 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.2 | 3.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 3.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 65.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 3.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 3.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.1 | 2.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 2.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 6.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.9 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 6.7 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 2.0 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 1.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 1.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 2.0 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.8 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 2.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.6 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 27.5 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 4.1 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.0 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.0 | GO:1901338 | catecholamine binding(GO:1901338) |
0.0 | 0.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 4.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 1.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.1 | GO:0052760 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 3.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 3.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 4.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 7.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 8.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 12.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 6.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 2.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 24.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 6.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 31.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 14.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 2.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 18.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 29.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 26.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 3.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.1 | 11.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 10.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 5.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 9.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 8.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.7 | 10.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 31.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 11.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 17.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 13.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 8.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 6.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 13.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 6.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 10.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.5 | 10.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 5.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 3.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 3.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 9.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 9.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 6.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 5.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 4.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 2.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 5.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 3.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 8.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 6.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 4.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 14.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 14.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 5.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 7.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 26.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 5.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.2 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 2.5 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 3.2 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 5.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 3.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |